Sarah Reiter serves as Executive at Arcadia Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Sarah Reiter has executed 5 insider transactions totaling $18.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 8, 2021 involved receiving (via award) 11,601 shares valued at $0.
Sarah Reiter currently holds 21,101 shares of Arcadia Biosciences, Inc. (RKDA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Reiter has been a net buyer of RKDA stock. They have purchased $18.9K and sold $0 worth of shares.
Sarah Reiter's most recent insider trade was on Jun 8, 2021, when they sold 11,601 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.72 |
| Discretionary |
| Dec 23, 2019 | RKDA | $5.4K | Purchase | 900 | $5.95 | Discretionary |
| Nov 19, 2019 | RKDA | $4.5K | Purchase | 1,000 | $4.52 | Discretionary |
| Sep 10, 2019 | RKDA | $7.8K | Purchase | 1,200 | $6.48 | Discretionary |